Perspective Therapeutics (CATX) EBIT (2010 - 2026)

Perspective Therapeutics recorded quarterly EBIT of -$28.3 million in Q1 2026, up 29.0% quarter-over-quarter from -$39.8 million in Q4 2025, and down 29.54% year-over-year from -$40.1 million in Q1 2025.

Perspective Therapeutics' EBIT history runs 17 years deep, the most recent figure standing at -$28.3 million for Q1 2026.

  • In Q1 2026, EBIT fell 29.54% year-over-year to -$28.3 million; the TTM figure through Mar 2026 stood at -$120.0 million (down 20.36% YoY), while the FY2025 annual figure was -$113.6 million, down 24.95% from the prior year.
  • EBIT came in at -$28.3 million for Q1 2026 at Perspective Therapeutics, up from -$39.8 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$1.4 million in Q1 2022 to a low of -$45.0 million in Q4 2024.
  • A 5-year average of -$16.9 million and a median of -$13.0 million in 2024 frame the typical range for EBIT.
  • Across the five-year window, EBIT slumped 609.38% in 2023 and gained 11.45% in 2025, its largest moves.
  • Perspective Therapeutics' EBIT stood at -$5.6 million in 2022, then tumbled by 107.72% to -$11.7 million in 2023, then tumbled by 285.27% to -$45.0 million in 2024, then increased by 11.45% to -$39.8 million in 2025, then gained by 29.0% to -$28.3 million in 2026.
  • According to Business Quant data, EBIT over the past three periods registered -$28.3 million, -$39.8 million, and -$27.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.35 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 936.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.46 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.10 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 477.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 282.15 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 255.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 515.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 316.80 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -28.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.28 Mn
Dec 31, 2025 -39.83 Mn
Sep 30, 2025 -27.86 Mn
Jun 30, 2025 -24.04 Mn
Mar 31, 2025 -21.83 Mn
Dec 31, 2024 -44.98 Mn
Sep 30, 2024 -18.63 Mn
Jun 30, 2024 -14.26 Mn
Mar 31, 2024 -13.01 Mn
Dec 31, 2023 -11.68 Mn
Sep 30, 2023 -9.75 Mn
Jun 30, 2023 -9.75 Mn
Mar 31, 2023 -9.76 Mn
Dec 31, 2022 -5.62 Mn
Sep 30, 2022 -4.21 Mn
Jun 30, 2022 -2.11 Mn
Mar 31, 2022 -1.38 Mn
Dec 31, 2021 -1.64 Mn
Sep 30, 2021 -2.27 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 -766,000.00
Dec 31, 2020 -873,000.00
Sep 30, 2020 -714,000.00
Jun 30, 2020 -1.19 Mn
Mar 31, 2020 -548,000.00
Dec 31, 2019 -903,000.00
Sep 30, 2019 -836,000.00
Jun 30, 2019 -1.14 Mn
Mar 31, 2019 -1.16 Mn
Dec 31, 2018 -1.43 Mn
Sep 30, 2018 -1.52 Mn
Jun 30, 2018 -2.37 Mn
Mar 31, 2018 -1.34 Mn
Dec 31, 2017 -1.47 Mn
Sep 30, 2017 -1.55 Mn
Jun 30, 2017 -1.86 Mn
Mar 31, 2017 -1.39 Mn
Dec 31, 2016 -1.48 Mn
Sep 30, 2016 -1.58 Mn
Jun 30, 2016 -1.25 Mn
Mar 31, 2016 -1.33 Mn
Dec 31, 2015 -1.41 Mn
Sep 30, 2015 -1.09 Mn
Jun 30, 2015 -1.10 Mn
Mar 31, 2015 -1.05 Mn
Dec 31, 2014 -1.02 Mn
Sep 30, 2014 -1.16 Mn
Jun 30, 2014 -1.32 Mn
Mar 31, 2014 -988,995.00
Dec 31, 2013 -1.04 Mn
Sep 30, 2013 -1.23 Mn
Jun 30, 2013 -1.02 Mn
Mar 31, 2013 -824,120.00
Dec 31, 2012 -1.10 Mn
Sep 30, 2012 -1.12 Mn
Jun 30, 2012 -940,653.00
Mar 31, 2012 -762,859.00
Dec 31, 2011 -792,051.00
Sep 30, 2011 -1.10 Mn
Jun 30, 2011 -766,384.00
Mar 31, 2011 -693,438.00
Dec 31, 2010 -634,636.00
Sep 30, 2010 -868,480.00